E727-0509 Screening compound: N-{3-[4-(4-methoxyphenyl)piperazin-1-yl]propyl}-2-(methylsulfanyl)-4-phenylpyrimidine-5-carboxamide

E727-0509 Screening compound: N-{3-[4-(4-methoxyphenyl)piperazin-1-yl]propyl}-2-(methylsulfanyl)-4-phenylpyrimidine-5-carboxamide
E727-0509 Screening compound: N-{3-[4-(4-methoxyphenyl)piperazin-1-yl]propyl}-2-(methylsulfanyl)-4-phenylpyrimidine-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E727-0509
N-{3-[4-(4-methoxyphenyl)piperazin-1-yl]propyl}-2-(methylsulfanyl)-4-phenylpyrimidine-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E727-0509

Molecular Formula

C26H31N5O2S (C26 H31 N5 O2 S)

Compound Name

N-{3-[4-(4-methoxyphenyl)piperazin-1-yl]propyl}-2-(methylsulfanyl)-4-phenylpyrimidine-5-carboxamide

IUPAC name

N-{3-[4-(4-methoxyphenyl)piperazin-1-yl]propyl}-2-(methylsulfanyl)-4-phenylpyrimidine-5-carboxamide

SMILES

COc(cc1)ccc1N1CCN(CCCNC(c(cn2)c(-c3ccccc3)nc2SC)=O)CC1

InChI

InChI=1S/C26H31N5O2S/c1-33-22-11-9-21(10-12-22)31-17-15-30(16-18-31)14-6-13-27-25(32)23-19-28-26(34-2)29-24(23)20-7-4-3-5-8-20/h3-5,7-12,19H,6,13-18H2,1-2H3,(H,27,32)

InChI Key

QYZDASURNFWUQX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14913009

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

477.63

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.892

Distribution Coefficient, logD

3.348

Water Solubility, LogSw

-3.85

Polar Surface Area

57.594

Acid Dissociation Constant (pKa)

14.66

Base Dissociation Constant (pKb)

7.80

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.60

E727-0509 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E727-0509 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E727-0509?
Check Price and Availability of E727-0509, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E727-0509 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E727-0509
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E727-0509
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E727-0509 available by request